These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34525261)

  • 1. Re: Effectiveness of hypertonic saline nebulization in airway clearance in children with noncystic fibrosis bronchiectasis: A randomized control trial.
    Valji R; Mehta R; Hicks A
    Pediatr Pulmonol; 2021 Dec; 56(12):4051-4052. PubMed ID: 34525261
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
    Anuradha KWDA; Gunathilaka PKG; Wickramasinghe VP
    Pediatr Pulmonol; 2021 Feb; 56(2):509-515. PubMed ID: 33295693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.
    Xie B; Liu P; Wu Q; Xiang W
    Am J Emerg Med; 2020 Dec; 38(12):2713-2717. PubMed ID: 33046287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
    Máiz Carro L; Martínez-García MA
    Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
    Koskela H; Purokivi M
    Duodecim; 2011; 127(24):2653-9. PubMed ID: 22320108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic options for noncystic fibrosis bronchiectasis.
    Yap VL; Metersky ML
    Curr Opin Infect Dis; 2015 Apr; 28(2):171-6. PubMed ID: 25692269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of nebulized hypertonic saline in patients with bronchial hypersecretion.
    González-Montaos A; Ramos-Hernández C; Lojo-Rodríguez I; Núñez-Fernández M; Fernández-Villar A
    Med Clin (Barc); 2023 Jan; 160(1):23-26. PubMed ID: 35931569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis.
    Harvath Gray EM; Pettit RS; Engdahl S
    Ann Pharmacother; 2024 Sep; ():10600280241279602. PubMed ID: 39297217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
    Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
    Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-cystic fibrosis bronchiectasis [corrected]].
    Ringshausen FC; Rademacher J; Welte T
    Dtsch Med Wochenschr; 2014 Apr; 139(14):707-10. PubMed ID: 24668431
    [No Abstract]   [Full Text] [Related]  

  • 19. New treatment options for bronchiectasis.
    Metersky ML
    Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.